Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd.

This early-stage trial is testing a new oral drug called F-02-2-Na in 69 adults with high uric acid levels, with or without gout. The main goal is to check the drug's safety and how the body processes it at different doses. Participants will receive either the drug or a placebo, …

This early-stage trial is testing a new drug called F-02-2-Na, designed to lower uric acid levels in people with gout or high uric acid. The study will give 12 healthy adults a single dose of the drug, once on an empty stomach and once after a meal, to see if food changes how the…